These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29471674)

  • 1. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
    Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yamakawa K; Ogura H; Fujimi S; Morikawa M; Ogawa Y; Mohri T; Nakamori Y; Inoue Y; Kuwagata Y; Tanaka H; Hamasaki T; Shimazu T
    Intensive Care Med; 2013 Apr; 39(4):644-52. PubMed ID: 23361628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.
    Yoshimura J; Yamakawa K; Ogura H; Umemura Y; Takahashi H; Morikawa M; Inoue Y; Fujimi S; Tanaka H; Hamasaki T; Shimazu T
    Crit Care; 2015 Mar; 19(1):78. PubMed ID: 25883031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation.
    Umegaki T; Kunisawa S; Nishimoto K; Kamibayashi T; Imanaka Y
    Sci Rep; 2020 Mar; 10(1):4874. PubMed ID: 32184456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Murao A; Kato T; Yamane T; Honda G; Eguchi Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation.
    Kotake K; Hongo T; Tahira A; Niimi N; Haisa I; Kawakami Y
    Biol Pharm Bull; 2021 May; 44(5):605-610. PubMed ID: 33612566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.
    Yamakawa K; Fujimi S; Mohri T; Matsuda H; Nakamori Y; Hirose T; Tasaki O; Ogura H; Kuwagata Y; Hamasaki T; Shimazu T
    Crit Care; 2011; 15(3):R123. PubMed ID: 21569368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis.
    Kato H; Hagihara M; Asai N; Umemura T; Hirai J; Mori N; Yamagishi Y; Iwamoto T; Mikamo H
    Thromb Res; 2023 Jun; 226():165-172. PubMed ID: 37182388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
    Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
    BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Human Soluble Thrombomodulin Contributes to a Reduction In-Hospital Mortality of Acute Cholangitis with Disseminated Intravascular Coagulation: A Propensity Score Analyses of a Japanese Nationwide Database.
    Tarasawa K; Fujimori K; Fushimi K
    Tohoku J Exp Med; 2020 Sep; 252(1):53-61. PubMed ID: 32879147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis.
    Ogawa Y; Yamakawa K; Ogura H; Kiguchi T; Mohri T; Nakamori Y; Kuwagata Y; Shimazu T; Hamasaki T; Fujimi S
    J Trauma Acute Care Surg; 2012 May; 72(5):1150-7. PubMed ID: 22673239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.
    Yoshihara M; Uno K; Tano S; Mayama M; Ukai M; Kondo S; Kokabu T; Kishigami Y; Oguchi H
    Crit Care; 2015 Oct; 19():369. PubMed ID: 26481315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.